HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

admin - April 11, 2025

Latest Pharma-News

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

admin - April 9, 2025

Latest Pharma-News

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

admin - April 9, 2025

Latest Pharma-News

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

admin - April 9, 2025

Latest Pharma-News

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

admin - February 10, 2025

Latest Pharma-News

FDA grants Breakthrough Therapy Designation for Roche’s Esbriet (pirfenidone) in unclassifiable interstitial lung disease

admin - March 3, 2020 0

Latest Pharma-News

Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to the respirators, including N95s, for the health care personnel

admin - March 3, 2020 0

Latest Pharma-News

FDA allows labs margin in testing for coronavirus

admin - March 2, 2020 0

Latest Pharma-News

USFDA Approves First Generic of Daraprim

admin - March 2, 2020 0

Latest Pharma-News

USFDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for the treatment of HER2-positive breast cancer

admin - February 28, 2020 0

Latest Pharma-News

Sanofi to create new industry-leading European company to provide active pharmaceutical ingredients

admin - February 28, 2020 0

Latest Pharma-News

AstraZeneca divests global rights to Movantik (naloxegol)

admin - February 27, 2020 0

Latest Pharma-News

Y-mAbs Announces Positive Pre-Biologics License Application Meeting with FDA for Omburtamab

admin - February 27, 2020 0

Latest Pharma-News

NIH clinical trial of remdesivir to treat coronavirus disease 2019 (COVID-19) begins

admin - February 27, 2020 0

Latest Pharma-News

Novartis announces FDA and EMA filing acceptance of ofatumumab (OMB157), a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)

admin - February 27, 2020 0

Latest Pharma-News

Novartis receives EC Approval for Beovu®(brolucizumab), a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide

admin - February 20, 2020 0

Latest Pharma-News

US FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)

admin - February 19, 2020 0

1...127128129...145 Page 128 of 145

Most Read

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

April 11, 2025

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 9, 2025

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

April 9, 2025

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

April 9, 2025

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved